Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,580.0,1.0,L452R + T478K,452,L452R + T478K,1,=,569.0,1.0,=,1.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1454.0,1.0,L452R + T478K,452,L452R + T478K,1,=,1134.0,1.0,=,1.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1582.0,1.0,L452R + T478K,452,L452R + T478K,1,=,1498.0,1.0,=,1.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2180.0,1.0,L452R + T478K,452,L452R + T478K,1,=,1534.0,1.0,=,1.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2340.0,1.0,L452R + T478K,452,L452R + T478K,1,=,796.0,1.0,=,2.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2881.0,1.0,L452R + T478K,452,L452R + T478K,1,=,2037.0,1.0,=,1.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3943.0,1.0,L452R + T478K,452,L452R + T478K,1,=,3496.0,1.0,=,1.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,608.0,1.0,L452R + T478K,452,L452R + T478K,1,=,587.0,1.0,=,1.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,625.0,1.0,L452R + T478K,452,L452R + T478K,1,=,595.0,1.0,=,1.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,893.0,1.0,L452R + T478K,452,L452R + T478K,1,=,574.0,1.0,=,1.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,912.0,1.0,L452R + T478K,452,L452R + T478K,1,=,759.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1177.0,1.0,L452R + T478K,452,L452R + T478K,1,=,837.0,1.0,=,1.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1190.0,1.0,L452R + T478K,452,L452R + T478K,1,=,658.0,1.0,=,1.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1309.0,1.0,L452R + T478K,452,L452R + T478K,1,=,1689.0,1.0,=,0.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1357.0,1.0,L452R + T478K,452,L452R + T478K,1,=,477.0,1.0,=,2.8